Andrew Carr
Andrew Carr
St Vincent's Hospital and University of New South Wales, Sydney
Verified email at stvincents.com.au
TitleCited byYear
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
A Carr, K Samaras, S Burton, M Law, J Freund, DJ Chisholm, DA Cooper
Aids 12 (7), F51-F58, 1998
27631998
Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial
ME Hannah, WJ Hannah, SA Hewson, ED Hodnett, S Saigal, AR Willan, ...
The Lancet 356 (9239), 1375-1383, 2000
20232000
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
19092003
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
A Carr, K Samaras, A Thorisdottir, GR Kaufmann, DJ Chisholm, ...
The Lancet 353 (9170), 2093-2099, 1999
17611999
Adverse effects of antiretroviral therapy
A Carr, DA Cooper
The Lancet 356 (9239), 1423-1430, 2000
13852000
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-Møller, ...
Archives of internal medicine 166 (15), 1632-1641, 2006
13112006
Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
A Carr, K Samaras, DJ Chisholm, DA Cooper
The Lancet 351 (9119), 1881-1883, 1998
12261998
Cardiovascular risk and body-fat abnormalities in HIV-infected adults
S Grinspoon, A Carr
New England Journal of Medicine 352 (1), 48-62, 2005
12202005
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
9802008
A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome
A Carr, J Miller, M Law, DA Cooper
Aids 14 (3), F25-F32, 2000
7192000
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease
SA Danner, A Carr, JM Leonard, LM Lehman, F Gudiol, J Gonzales, ...
New England Journal of Medicine 333 (23), 1528-1534, 1995
6241995
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel
M Schambelan, CA Benson, A Carr, JS Currier, MP Dubé, JG Gerber, ...
J Acquir Immune Defic Syndr 31 (3), 257-75, 2002
5492002
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study
A Carr, HIV Lipodystrophy Case Definition Study Group
The Lancet 361 (9359), 726-735, 2003
5362003
Major clinical outcomes in antiretroviral therapy (ART)–naive participants and in those not receiving ART at baseline in the SMART study
Strategies for Management of Antiretroviral Therapy (SMART) Study Group
The Journal of infectious diseases 197 (8), 1133-1144, 2008
5062008
Genetic characterization of human immunodeficiency virus type 1 in blood and genital secretions: evidence for viral compartmentalization and selection during sexual transmission.
T Zhu, N Wang, A Carr, DS Nam, R Moor-Jankowski, DA Cooper, DD Ho
Journal of virology 70 (5), 3098-3107, 1996
5061996
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
MA Jacobson, M Zegans, PR Pavan, JJ O'Donnell, F Sattler, N Rao, ...
The Lancet 349 (9063), 1443-1445, 1997
4971997
Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
A Carr, D Marriott, A Field, E Vasak, DA Cooper
The Lancet 351 (9098), 256-261, 1998
3811998
Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir
AD Kelleher, A Carr, J Zaunders, DA Cooper
Journal of Infectious Diseases 173 (2), 321-329, 1996
3711996
Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial
A Carr, C Workman, DE Smith, J Hoy, J Hudson, N Doong, A Martin, ...
Jama 288 (2), 207-215, 2002
3702002
Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy
PWG Mallon, J Miller, DA Cooper, A Carr
Aids 17 (7), 971-979, 2003
3692003
The system can't perform the operation now. Try again later.
Articles 1–20